Despite all this, the levels of FGF-21 and GDF-15 are likely influenced by age, body max index (BMI) and some certain diseases (e.g. heart failure, myocardial infarction, pulmonary hypertension, diabetes, metabolic syndrome, autoimmune diseases, and cancer) [38, 39]. This evidence concerns the gene GDF15 and pulmonary hypertension.